Cover Image

METTL3-mediated HPV vaccine enhances the effect of anti PD-1 immunotherapy to alleviate the development of cutaneous squamous cell carcinoma

Abstract Background Cutaneous squamous cell carcinoma (cSCC) develops from epithelial keratinocytes by dysregulation of self-renewal and differentiation. Recent studies have found that the size and number of cSCC tumors gradually decrease or even disappear after HPV vaccination. However, the role of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yingjie Zhang (Author), Yiru Wang (Author), Shuping Guo (Author), Hongzhou Cui (Author)
Format:	Book
Published:	Sociedade Brasileira de Dermatologia, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
by: Nader Aboul-Fettouh, et al.
Published: (2021)

METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification
by: Wei Zhao, et al.
Published: (2020)

PD-L1 immunohistochemical expression considering HPV status in oropharyngeal squamous cell carcinoma
by: Raíssa Soares dos ANJOS, et al.
Published: (2024)

Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges
by: Luigi Lorini, et al.
Published: (2023)

Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma
by: Xiangye Yin, et al.
Published: (2024)

METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma
by: Fangfang Ge, et al.
Published: (2022)

[Translated article] Locally Advanced Cutaneous Squamous Cell Carcinoma Treated With Immunotherapy in a Dermatology Department
by: I. Navarro Navarro, et al.
Published: (2023)

The Mettle of the Pasture
by: Allen, James Lane, 1849-1925

Chinese mettle
by: Kemp, E. G. (Emily Georgiana), 1860-1939; Sze, Sao-Ke Alfred, 1877-1958 [Author of introduction, etc.]

Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
by: Xi Chen, et al.
Published: (2020)

Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa
by: Laura Trefzer, et al.
Published: (2023)

CUTANEOUS SQUAMOUS CELL CARCINOMA IN CHILDREN
by: Georgiana-Cristina Ionescu, et al.
Published: (2015)

Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
by: Guilan Shi, et al.
Published: (2022)

Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
by: Hong Kyu Lee, et al.
Published: (2020)

Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
by: Yunna Chen, et al.
Published: (2024)

Bibliometric analysis of immunotherapy for head and neck squamous cell carcinoma
by: Xin-Jia Cai, et al.
Published: (2023)

Advanced squamous cell carcinoma and immunotherapy: new therapeutic perspectives
by: Magda Blessmann Weber, et al.
Published: (2021)

Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress
by: Ziwei Li, et al.
Published: (2024)

A Lad of Mettle
by: Gould, Nat, 1857-1919

Treating locally advanced and metastatic cutaneous squamous cell carcinoma with anti-PD-1 drugs: Real-world experience in 72 patients
by: Robin M. Picavia, BS, et al.
Published: (2024)

Cutaneous metastasis of PD-L1 positive ovarian carcinoma
by: Victoria Hastings, et al.
Published: (2020)

Cutaneous metastasis of PD-L1 positive cervical carcinoma
by: Chrissy Liu, et al.
Published: (2022)

Update of the Management of Cutaneous Squamous-cell Carcinoma
by: Eve Maubec
Published: (2020)

Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
by: Marcos Oro-Ayude, et al.
Published: (2020)

Immunohistochemical staining of Langerhans cells in HPV-positive and HPV-negative cases of oral squamous cells carcinoma
by: Karuza Maria Alves Pereira, et al.
Published: (2011)

Immunohistochemical staining of Langerhans cells in HPV-positive and HPV-negative cases of oral squamous cells carcinoma
by: Karuza Maria Alves Pereira, et al.
Published: (2011)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
by: Jinhua Liu, et al.
Published: (2021)

Prognostic significance of HPV16 infection in oral squamous cell carcinoma
by: Antunović Marija, et al.
Published: (2023)

High incidence of HPV infection in minors with oral squamous cell carcinoma
by: Ningxiang Wu, et al.
Published: (2024)

HPV detection in floor of mouth squamous cell carcinoma by PCR amplification
by: Luciana E. Simonato, et al.

PD-1 Alleviates Cisplatin-Induced Muscle Atrophy by Regulating Inflammation and Oxidative Stress
by: Xiaoguang Liu, et al.
Published: (2022)

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy
by: Xuefen Zhuang, et al.
Published: (2024)

MiR-526b-3p enhances sensitivity of head and neck squamous cell carcinoma cells to radiotherapy via suppressing exosomal LAMP3-mediated autophagy
by: Huixiang Lu, et al.
Published: (2023)

Acidic/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapy
by: Xiaoju Guo, et al.
Published: (2024)

Cutaneous squamous cell carcinoma in background of chronic arsenicosis
by: Sweta Subhadarshani, et al.
Published: (2020)

Aberrant DNA Methylation in Cutaneous Squamous Cell Carcinoma
by: Feng-Juan Li, et al.
Published: (2019)

Deep mycosis mimicking cutaneous squamous cell carcinoma
by: Fortunato Cassalia, et al.
Published: (2023)

Statins Inhibit Cutaneous Squamous Cell Carcinoma Cells
by: Asher Hackett, et al.
Published: (2024)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021)

Beyond PD-1 Immunotherapy in Malignant Melanoma
by: Dominika Kwiatkowska, et al.
Published: (2019)